News
Ironically, many of the staff who have already been laid off from the FDA were experts in AI modelling and machine learning, Cadotte said. "With the February 14th layoffs, 75% of those [AI experts ...
The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results